×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
XLO – xilio therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
XLO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/2
08:01 am
xlo
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/2
08:00 am
xlo
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
Medium
Report
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
3/2
07:30 am
xlo
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/12
02:35 am
xlo
Xilio Therapeutics prices $40M stock offering [Seeking Alpha]
Medium
Report
Xilio Therapeutics prices $40M stock offering [Seeking Alpha]
2/11
09:34 pm
xlo
Xilio Therapeutics Announces Pricing of Underwritten Offering
Medium
Report
Xilio Therapeutics Announces Pricing of Underwritten Offering
1/8
08:30 am
xlo
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
Low
Report
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
12/30
04:16 pm
xlo
Xilio Therapeutics (NASDAQ:XLO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Xilio Therapeutics (NASDAQ:XLO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/16
04:43 pm
xlo
Xilio Therapeutics (NASDAQ:XLO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Xilio Therapeutics (NASDAQ:XLO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/24
07:30 am
xlo
Form 8-K Xilio Therapeutics, Inc. For: Feb 23
Medium
Report
Form 8-K Xilio Therapeutics, Inc. For: Feb 23
2/17
05:32 pm
xlo
Form 4 Xilio Therapeutics, Inc. For: Feb 13 Filed by: GILEAD SCIENCES, INC.
Medium
Report
Form 4 Xilio Therapeutics, Inc. For: Feb 13 Filed by: GILEAD SCIENCES, INC.
2/17
04:31 pm
xlo
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
Medium
Report
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
2/17
10:00 am
xlo
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: STEMPOINT CAPITAL LP
Low
Report
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: STEMPOINT CAPITAL LP
2/13
05:32 pm
xlo
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Medium
Report
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
2/12
04:51 pm
xlo
Form 8-K Xilio Therapeutics, Inc. For: Feb 11
Low
Report
Form 8-K Xilio Therapeutics, Inc. For: Feb 11
2/12
04:50 pm
xlo
Form 424B5 Xilio Therapeutics, Inc.
Low
Report
Form 424B5 Xilio Therapeutics, Inc.
2/12
04:40 pm
xlo
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: GILEAD SCIENCES, INC.
Low
Report
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: GILEAD SCIENCES, INC.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: